Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs

Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs

Abstract Background In 2013, Jinan KingMed Diagnostics (JKD) first established a systematic cervical cytology training and quality control (QC) program in Shandong Province, China. We compared the efficacy of high-risk human papillomavirus (HR-HPV) detection, cytology, and their combination in routi...

Full description

Bibliographic Details
Main Authors: Dongman Zhao, Liran Zhang, Fengxiang Xie, Dezhi Peng, Jie Wei, Lingbo Jiang, Shoudu Zhang, Debo Qi
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Cancer
Subjects:
Cervical intraepithelial neoplasia
Cervical cancer
Screening
Cervical cytology
High-risk human papillomavirus (HR-HPV)
Co-testing
Online Access:http://link.springer.com/article/10.1186/s12885-020-07321-2

Internet

http://link.springer.com/article/10.1186/s12885-020-07321-2

Similar Items